ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 241 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,051,000 | +95.4% | 11,310 | +25.2% | 0.01% | +66.7% |
| Q3 2021 | $538,000 | +6.3% | 9,030 | +21.8% | 0.00% | 0.0% |
| Q2 2021 | $506,000 | +16.1% | 7,416 | +18.1% | 0.00% | +50.0% |
| Q1 2021 | $436,000 | +10.9% | 6,278 | +22.9% | 0.00% | 0.0% |
| Q4 2020 | $393,000 | +65.1% | 5,109 | +60.6% | 0.00% | 0.0% |
| Q3 2020 | $238,000 | -10.5% | 3,182 | -45.0% | 0.00% | 0.0% |
| Q3 2018 | $266,000 | -37.0% | 5,790 | -40.2% | 0.00% | -33.3% |
| Q2 2018 | $422,000 | +23.0% | 9,685 | +11.5% | 0.00% | +50.0% |
| Q1 2018 | $343,000 | -22.9% | 8,685 | -33.6% | 0.00% | -33.3% |
| Q4 2017 | $445,000 | – | 13,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |